|
December 5, 2006 - Cancer Chemoprevention: A Discussion of Benefits and Risks
Featuring Dr. Worta McCaskill-Stevens, Medical Oncologist and Program Director of the NCI Division of Cancer Prevention; Dr. Larry Wickerham, Associate Chairman of the National Surgical Adjuvant Breast and Bowel Project (NSABP); Dr. Victor Vogel, Director of Magee Women's Breast Cancer Program at the University of Pittsburgh; Dr. Howard Parnes, Chief of the Prostate and Urologic Cancer, NCI Division of Cancer Prevention; Ms. Ann Marie Gugger, Participant Advisory Board of the National Surgical Adjuvant Breast and Bowel Project (NSABP); Mr. Julius Jones, Prostate Cancer Prevention Trial (PCPT) patient advocate and SELECT National Patient Advisory Board (NPAB); and Dr. Leslie Ford, Associate Clinical Director of the NCI Division of Cancer Prevention.
November 7, 2006 - What Advocates Should Know About Complementary and Alternative Medicine
Featuring Dr. Jeff White, Director, NCI Office of Cancer Complementary and Alternative Medicine (OCCAM); and Ms. Martha Powell, patient advocate.
October 31, 2006 - The Impact of Nanotechnology Research on Cancer Patients
Featuring Dr. Piotr Grodzinski, Director, NCI Alliance for Nanotechnology in Cancer; Mr. Travis Earles, Nanotechnology Project Manager, NCI Alliance for Nanotechnology in Cancer; and Mr. Wayland Eppard, patient advocate.
September 19, 2006 - Update for the Advocacy Community from NCI Director Dr. John Niederhuber
Featuring NCI Director, Dr. John Niederhuber, Mr. Doug Ulman, chair of the NCI Director's Consumer Liaison Group; and CARRA member, and DCLG Vice-Chair, Dr. Beverly Laird
September 13, 2006 - TCGA to Study Lung, Ovarian, and Brain Tumors
Featuring Dr. Francis Collins, NHGRI Director, Dr. Anna Barker, NCI Deputy Director, Dr. Carolyn Compton, Director of the Office of Biorepositories and Biospecimen Research; and Dr. Beverly Laird, Vice-Chair of the NCI Director's Consumer Liaison Group
June 29, 2006 - Translating Cancer Discovery into Improved Health Outcomes NCI's Office of Education and Special Initiatives
Featuring Ms. Lenora Johnson, Director of the Office of Education and Special Initiatives; Ms. Rose Mary Padberg, Chief, Cancer Education Branch, Office of Education and Special Initiatives; Ms. Sona Thakkar, Senior Public Health Educator, Office of Education and Special Initiatives; and advocate: Mr. Sanford Jeames, Patient Education Coordinator, Division of Urology at the University of Alabama at Birmingham.
May 17, 2006 - Why caBIG is Important to Advocates
Featuring Kenneth H. Buetow, Ph.D., Associate Director for Bioinformatics and Information Technology and Chief, Laboratory of Population Genetics, Center for Cancer Research; and Greg Bielawski, caBIGTM Patient Advocate and Member, NCI Consumer Advocates in Research and Related Activities
April 27, 2006 - Tissue Banking: An Introduction to the Issues Surrounding Biorepositories and Biospecimen Research
Featuring Carolyn Compton, MD, Ph.D. Director of Biorepositories and Biospecimen Research; and Paula Kim, NCI Board of Scientific Advisors Member/Advocate
March 16, 2006 - A Role for Advocates in NCI’s Work: The CARRA Program or Consumer Advocates in Research and Related Activities
Featuring Olivia Bartlett, Ph.D., Chief, Research Programs Review Branch, NCI Division of Extramural Activities; Louise Cunningham, Public Health Educator, NCI Office of Education and Special Initiatives; James L. Omel, M.D., Educator, International Myeloma Foundation and Member, NCI’s CARRA Program; and Jane Jacobs, CARRA Program Development Manager, NCI Office of Liaison Activities
February 28, 2006 - What Advocates Should Know about the Early Detection Research Network (EDRN)
Featuring Dr. Sudhir Srivastava, Ph.D., M.P.H., Director of the Early Detection Research Network (EDRN); and Mr. Bruce Mabrito, Director of the Central Proposal Office for the Southwest Research Network and active patient/advocate
February 14, 2006 - New Federal Health Initiative to Improve Cancer Therapy
Featuring Andrew C. von Eschenbach, M.D., Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration; Janet Woodcock, M.D., Deputy Commissioner for Operations, U.S. Food and Drug Administration; and Anna D. Barker, Ph.D., Deputy Director, National Cancer Institute
Teleconference Transcript [Microsoft Word, 61kb]
^ Back to Top
|